Novo Nordisk

Pfizer has filed a second lawsuit against Metsera, its controlling stockholders, and Novo Nordisk A/S in the United States…

Mid-stage trial results show sustained blood sugar reduction and potential benefit for patients unresponsive to GLP-1 therapies

As the world evolves at a rapid pace, pharma companies are embracing smarter approaches, leveraging AI across nearly every aspect…

With semaglutide patents set to expire in 2026, Indian drugmakers are preparing to enter the market with generics. This…

The recent data from the STEER real-world study of evidence gathered from actual patient experiences at the European Society of…

Seven out of the top 20 companies registered over 10 per cent YoY revenue growth from 2023 to 2024

Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India

Doctors have warned of the risk of overuse and misuse, cautioning that patients will see such medications as an easy, quick fix,…

ATMF report recommends practical solutions whereby companies can bring about the fundamental shift that is required to scale up…

Chakravarthi AVPS delivers special address on drug safety and moderates key discussion at PHARMAP 2025, shaping the future of…